International Patent: DUAL GLUCAGON INSULIN AGONISTS AND METHODS OF USE THEREOF

GENEVA, Sept. 7 -- AMIDEBIO, LLC filed a patent application (US2026/017150) for “DUAL GLUCAGON INSULIN AGONISTS AND METHODS OF USE THEREOF”. With publication no. WO/2026/183519, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 14/605

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....